William D Young's Net Worth
$15.4 Million
Who is William D Young?
William D Young has an estimated net worth of $15.4 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, THERAVANCE INC, BIOMARIN PHARMACEUTICAL INC, Praxis Precision Medicines, Inc., Theravance Biopharma, Inc., HUMAN GENOME SCIENCES INC, VAXGEN INC, and Monogram Biosciences, Inc..
SEC CIK
William D Young's CIK is 0001217420
Past Insider Trading and Trends
2008 was William D Young's most active year for acquiring shares with 13 total transactions. William D Young's most active month to acquire stocks was the month of April. 2019 was William D Young's most active year for disposing of shares, totalling 5 transactions. William D Young's most active month to dispose stocks was the month of November. 2019 saw William D Young paying a total of $1,969,500.00 for 46,766 shares, this is the most they've acquired in one year. In 2019 William D Young cashed out on 60,000 shares for a total of $6,562,715.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $418.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
$145.54 | -$2,935,895.76 | 9.31K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$142.20 | -$4,593,215.24 | 9.31K |
Scheduled
|
Dec 30
| ||
Form 4
| +34.36% | 2.38K |
—
|
—
| 9.31K |
Jun 1
| |||
Form 4
| +35.11% | 1.8K |
—
|
—
| 6.93K |
Jun 1
| |||
Form 4
| +74.40% | 2.19K |
—
|
—
| 5.13K |
Jun 1
| |||
Form 4
|
∞
| 2.94K |
$0.01 | $29.41 | 2.94K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THERAVANCE INC (INVA) Snapshot price: $15.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.70% | 6K |
—
|
—
| 83.94K |
May 22
| |||
Form 4
| +49.50% | 25.81K |
$9.69 | $249,995.63 | 77.94K |
Apr 7
| |||
Form 4
| +13.01% | 6K |
—
|
—
| 52.13K |
Apr 24
| |||
Form 4
| +14.95% | 6K |
—
|
—
| 46.13K |
May 15
| |||
Form 4
| +17.58% | 6K |
—
|
—
| 40.13K |
Apr 27
| |||
Form 4
| +18.70% | 5.38K |
$15.42 | -$28,277.76 | 34.13K |
Mar 7
| |||
Form 4
| +23.00% | 5.38K |
$15.88 | -$33,169.92 | 28.75K |
Feb 18
| |||
Form 4
| +29.87% | 5.38K |
$17.59 | -$51,565.43 | 23.38K |
Dec 10
| |||
Form 4
| +50.00% | 6K |
—
|
—
| 18K |
Apr 27
| |||
Form 4
| +100.00% | 6K |
—
|
—
| 12K |
Apr 24
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Apr 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $89.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.21% | 1.1K |
—
|
—
| 11.88K |
Jun 10
| |||
Form 4
| +24.21% | 2.1K |
—
|
—
| 10.78K |
Jun 4
| |||
Form 4
| +64.45% | 3.4K |
—
|
—
| 8.68K |
May 15
| |||
Form 4
| +181.33% | 3.4K |
—
|
—
| 5.28K |
May 8
| |||
Form 4
|
∞
| 1.88K |
—
|
—
| 1.88K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $44.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 28.47K |
—
|
—
| 28.47K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.45% | 9.85K |
—
|
—
| 78.01K |
Apr 26
| |||
Form 4
| +16.85% | 9.83K |
—
|
—
| 68.16K |
Apr 27
| |||
Form 4
| +12.83% | 6.63K |
—
|
—
| 58.33K |
Apr 28
| |||
Form 4
| +19.36% | 8.38K |
—
|
—
| 51.7K |
Apr 30
| |||
Form 4
| +23.31% | 8.19K |
—
|
—
| 43.31K |
May 1
| |||
Form 4
| +20.60% | 6K |
—
|
—
| 35.12K |
May 17
| |||
Form 4
| +25.95% | 6K |
—
|
—
| 29.12K |
May 3
| |||
Form 4
| +35.04% | 6K |
—
|
—
| 23.12K |
Apr 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||